Supernus Pharmaceuticals Inc (SUPN) valuation · rev $719.0M
Supernus Pharmaceuticals Inc (SUPN) rev $719.0M.
| Metric | Value |
|---|---|
| Market cap | $2.53B |
| Revenue | $719.0M |
| P/S | 3.5 |
| P/B | 2.3 |
SUPN valuation FAQ
What is SUPN's market cap?
Supernus Pharmaceuticals Inc (SUPN) market cap is $2.53B on the latest cached fundamentals snapshot.
What is SUPN's latest revenue?
Latest cached Supernus Pharmaceuticals Inc (SUPN) revenue was $719.0M. Statements: https://lician.com/financials/supn
What is SUPN's price-to-sales ratio?
Supernus Pharmaceuticals Inc (SUPN) price-to-sales (P/S) is 3.5, cached market cap $2.53B divided by revenue $719.0M.
What is SUPN's price-to-book ratio?
Supernus Pharmaceuticals Inc (SUPN) price-to-book (P/B) is 2.3 on the latest cached fundamentals snapshot.
How many SUPN valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Supernus Pharmaceuticals Inc (SUPN): Market cap, Revenue, P/S, and P/B.
Where is SUPN valuation listed?
Cached valuation multiples for Supernus Pharmaceuticals Inc (SUPN) are listed at https://lician.com/valuation/supn.
Not investment advice. Cached rows, not a live tape.